Axel Ullrich
- Molecular Biology top 2%
- Oncology top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Cancer Research top 1%
- Immunology top 5%
- Co-authors
- Klaus StrebhardtKarl H. PlateB MillauerJoseph SchlessingerLaura K. ShawverRobert M. HudziakGary C. ChamnessAmol Tandon
- Topics
- HER2/EGFR in Cancer Research (9 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)Glycosylation and Glycoproteins Research (6 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Axel Ullrich
54 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Molecular Biology 3.7k
- Oncology 2.2k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Cancer Research 1.1k
- Immunology 704
Countries citing papers authored by Axel Ullrich
This map shows the geographic impact of Axel Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Ullrich more than expected).
Fields of papers citing papers by Axel Ullrich
This network shows the impact of papers produced by Axel Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Ullrich. The network helps show where Axel Ullrich may publish in the future.
Co-authorship network of co-authors of Axel Ullrich
This figure shows the co-authorship network connecting the top 25 collaborators of Axel Ullrich. A scholar is included among the top collaborators of Axel Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Ullrich. Axel Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 27 | |
| 3 | 64 | |
| 4 | 5 | |
| 5 | Paul Ehrlich's magic bullet concept: 100 years of progressbreakdown → | 954 |
| 6 | 91 | |
| 7 | 39 | |
| 8 | 481 | |
| 9 | 58 | |
| 10 | 45 | |
| 11 | 5 | |
| 12 | 16 | |
| 13 | Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantbreakdown → | 1036 |
| 14 | Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. | 97 |
| 15 | 50 | |
| 16 | Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. | 142 |
| 17 | HER-2/neu oncogene protein and prognosis in breast cancer.breakdown → | 497 |
| 18 | 12 | |
| 19 | 32 | |
| 20 | Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.breakdown → | 541 |
About Axel Ullrich
Axel Ullrich is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 55 papers that have together received 6.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (1.1k citations) and Immunology and Allergy (349 citations). Axel Ullrich has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Klaus Strebhardt, Karl H. Plate, B Millauer, Joseph Schlessinger, Laura K. Shawver, Robert M. Hudziak, Gary C. Chamness, Amol Tandon, Gary M. Clark and Oliver Hobert. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.